Resultados da busca - Marc Ferrante
- Mostrando 1 - 20 resultados de 125
- Ir para a próxima página
-
1
-
2
-
3
New treatment options for inflammatory bowel diseases por Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche
Publicado em 2018Revisão -
4
-
5
-
6
Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors por Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire
Publicado em 2006Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis por Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire
Publicado em 2020Artigo -
14
-
15
-
16
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease por Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Publicado em 2018Artigo -
17
-
18
DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease por Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Publicado em 2021Artigo -
19
Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression por Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Publicado em 2022Artigo -
20
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis por Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante
Publicado em 2016Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Disease
Gastroenterology
Ulcerative colitis
Crohn's disease
Inflammatory bowel disease
Biology
Surgery
Infliximab
Immunology
Tumor necrosis factor alpha
Genetics
Adalimumab
Gene
Pathology
Physics
Biochemistry
Intensive care medicine
Vedolizumab
Chemotherapy
Colitis
Interquartile range
Retrospective cohort study
Cancer
Cell biology
Endoscopy
Odds ratio
Adverse effect
Confidence interval